Evidently, various reports have shown the elevated expression of USP22, CBX6, NRAGE, ACTL6, and CHMP4B genes correlate with larger tumor size, advanced tumor stages, poor prognosis and short survival time of patients in LIHC [16–20]. This evidence concerns the gene CHMP4B and neoplasm.